Anhui Huaren Health Pharmaceutical Co Ltd
SZSE:301408
Intrinsic Value
Anhui Huaren Health Pharmaceutical Co., Ltd. engages in pharmaceutical distribution. [ Read More ]
The intrinsic value of one Anhui Huaren Health Pharmaceutical Co Ltd stock under the Base Case scenario is 10.1 CNY. Compared to the current market price of 12.4 CNY, Anhui Huaren Health Pharmaceutical Co Ltd is Overvalued by 19%.
Valuation Backtest
Anhui Huaren Health Pharmaceutical Co Ltd
Run backtest to discover the historical profit from buying and selling Anhui Huaren Health Pharmaceutical Co Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
This note will be permanently deleted.
Balance Sheet Decomposition
Anhui Huaren Health Pharmaceutical Co Ltd
| Current Assets | 2.8B |
| Cash & Short-Term Investments | 593.1m |
| Receivables | 559.8m |
| Other Current Assets | 1.7B |
| Non-Current Assets | 1.8B |
| Long-Term Investments | 94.7m |
| PP&E | 870.1m |
| Intangibles | 671.8m |
| Other Non-Current Assets | 148.7m |
| Current Liabilities | 2B |
| Accounts Payable | 252.9m |
| Accrued Liabilities | 57.4m |
| Short-Term Debt | 1.3B |
| Other Current Liabilities | 306.5m |
| Non-Current Liabilities | 704.4m |
| Long-Term Debt | 568.8m |
| Other Non-Current Liabilities | 135.6m |
Earnings Waterfall
Anhui Huaren Health Pharmaceutical Co Ltd
|
Revenue
|
4.1B
CNY
|
|
Cost of Revenue
|
-2.8B
CNY
|
|
Gross Profit
|
1.2B
CNY
|
|
Operating Expenses
|
-1B
CNY
|
|
Operating Income
|
200.6m
CNY
|
|
Other Expenses
|
-67.7m
CNY
|
|
Net Income
|
133m
CNY
|
Free Cash Flow Analysis
Anhui Huaren Health Pharmaceutical Co Ltd
| CNY | |
| Free Cash Flow | CNY |
Profitability Score
Profitability Due Diligence
Anhui Huaren Health Pharmaceutical Co Ltd's profitability score is 49/100. The higher the profitability score, the more profitable the company is.
Score
Anhui Huaren Health Pharmaceutical Co Ltd's profitability score is 49/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Anhui Huaren Health Pharmaceutical Co Ltd's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Score
Anhui Huaren Health Pharmaceutical Co Ltd's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Anhui Huaren Health Pharmaceutical Co Ltd
Shareholder Return
Price
Anhui Huaren Health Pharmaceutical Co Ltd
| Average Annual Return |
N/A
|
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -60% |
| Market Capitalization | 5B CNY |
| Shares Outstanding | 400 009 984 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Anhui Huaren Health Pharmaceutical Co., Ltd. engages in pharmaceutical distribution. The company is headquartered in Hefei, Anhui and currently employs 5,785 full-time employees. The company went IPO on 2023-03-01. The pharmaceutical retail business is mainly engaged in the sales of medicines, health food and medical equipment, as well as the diagnosis and treatment of common diseases. The agency business mainly promotes and sells to downstream pharmaceutical retail enterprises. The terminal centralized procurement business mainly provides one-stop distribution services for individual pharmacies and small chain retail terminals.
Contact
IPO
Employees
Officers
The intrinsic value of one Anhui Huaren Health Pharmaceutical Co Ltd stock under the Base Case scenario is 10.1 CNY.
Compared to the current market price of 12.4 CNY, Anhui Huaren Health Pharmaceutical Co Ltd is Overvalued by 19%.
You don't have any saved screeners yet
